Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme

Temozolomide has established activity in the treatment of recurrent glioblastoma multiforme (GBM). Caelyx (liposomal doxorubicin) has established activity in a broad range of tumors but has not been extensively evaluated in the treatment of GBM. Phase 1 data suggest that temozolomide and Caelyx can...

Full description

Saved in:
Bibliographic Details
Main Authors: Chua, Susan L., Rosenthal, Mark A., Wong, Shirley S., Ashley, David M., Woods, Anne-marie, Dowling, Anthony, Cher, Lawrence M.
Format: Artigo
Language:Inglês
Published: Duke University Press 2004
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871967/
https://ncbi.nlm.nih.gov/pubmed/14769139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000188
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items